ABSTRACT
Systematic review-Dynamic stabilization versus fusion for treatment of degenerative spine conditions

STUDY RATIONALe AND CONTeXT
Spinal fusion is believed to accelerate the degeneration of the vertebral segment above or below the fusion site, a condition called adjacent segment disease (ASD) [1] . Dynamic stabilization systems have increased in popularity in the past decade as an alternative to fusion for treatment of degenerative spine conditions. In theory, they allow for less loading on the adjacent discs and facet joints and preserve adjacent segmental motion. Theoretically, this should lead to a decrease in ASD. However, it is unclear that such devices lead to better outcomes compared with traditional fusion, and it is unclear if it truly leads to a decrease in ASD.
CLINICAL QUeSTION
In patients 18 years or older, with degenerative disease of the cervical or lumbar spine, does dynamic stabilization lead to better outcomes and fewer complications, including ASD, than fusion in the short-term and long-term?
MeTHODS
Study design: Comparative effectiveness review.
Search: PubMed, EMBASE, Cochrane Database of Systematic Reviews, bibliographies of key articles.
Dates searched: up through March 7, 2011.
Inclusion criteria: Studies directly comparing dynamic stabilization devices with traditional fusion (CoE I-III) in patients 18 years or older with degenerative spine disease (including spinal stenosis, spondylosis, spondylolisthesis, and/or degenerative disc disease).
Exclusion criteria: Studies in patients younger than18 years, those with tumors, trauma, primary infection or inflammatory cause, fracture, Paget disease, osteochondrosis, congenital malformation, or visceral diseases, or previous lumbar surgery; studies comparing single versus multilevel dynamic stabilization without a comparison arm for fusion; studies of interspinous spacers (as sole device), dynamic devices, case series, non-human in vivo, in vitro, and biomechanical studies.
Outcomes: Visual analogue scale (VAS) for low back and lower leg pain; Oswestry disability index (ODI); ASD, reoperation, and other complications.
Analysis: Means and information on variation (eg, standard deviation or range) for continuous variables were abstracted from the report as available or if necessary, estimated from author figures and change scores calculated. The mean percentage improvement in the outcome score from baseline at each given follow-up time was calculated by dividing the change score by the baseline score to get the total percentage improvement. Rates of ASD, reoperation, and complications were calculated. Pooling of data was not done due to concerns regarding heterogeneity of treatments and populations as well as study quality.
Additional methodological and technical details are provided in the electronic supplemental material at www.aospine.org/ebsj.
ReSULTS
Most published reports were case series, in vitro or biomechanical studies. From a total of 79 citations retrieved, 14 were selected for full-text review (Fig 1) . Of these, five met the inclusion criteria; however, duplicate papers on the same population were found [2, 3] and the most updated study was included for analysis [2] . Thus, four relatively small comparative studies are critically summarized [2] [3] [4] [5] , three of which were prospective. Populations were predominantly female ( Table 1) . Different dynamic stabilization systems were used including: the Cosmic dynamic pedicle screw-rod system, Twinflex rod system, Interspinous Soft Stabilization (ISS) with tension band system, and dynamic (hinged) pedicle screws ( Table 2 ). All studies are class of evidence III.
Further details on the class of evidence rating for these studies can be found in the supplemental material at www.aospine.org/ebsj. 2 and 3; Table 3) • The mean percentage improvement in VAS pain scores was generally similar for both treatment groups for both low back pain and leg pain across studies.
VAS for low back pain and leg pain (Figs
• No statistically significant differences between treatment groups was seen in mean VAS scores for either low back pain or leg pain at follow-up times reported by authors. All authors reported improvement in VAS scores relative to preoperative values for both treatment groups.
Oswestry disability index (ODI) (Fig 4; Table 4)
• Treatment groups were similar with regard to mean percentage improvement in ODI scores.
• No statistically significant differences between treatment groups for mean ODI were reported at any Adjacent segment disease ( Table 5) • In the three studies that reported ASD [2, 4, 5] , ASD was not found in any of the patients treated with dynamic stabilization. In the fusion groups, occurrence of ASD ranged from 0%-9%. Table 5) • Definitions of and indications for reoperation varied across studies, the extent to which these were device related was not always clear. • In the dynamic groups, reoperation was reported in 0%-8% of patients primarily due to continued low back pain. • In the fusion groups, reoperation was reported in 0%-9% of patients for various indications including ASD, deep infection, hematoma, and pseudarthrosis.
Reoperation (
Other complications ( Table 5) • Reporting of complications varied across studies, and whether patients may have experienced more than one complication is generally not well delineated.
• In three studies, a higher number of complications overall was reported in the groups receiving fusion [2, 5, 6] . Complications included urinary tract infection, hematoma of the lumbar spine, deep infection, screw/rod breakage or loosening, radiolucency around screws, donor site pain, and fracture of the spinous process, pseudarthrosis, and malunion.
CLINICAL GUIDeLINeS
None found. Hinged-pedicle screws combined rigid rods Allows axial motion, reducing stress at the bone-screw interface Table 3 Mean visual analogue scale (VAS) (10 mm) pain scores* and change scores from baseline to follow-up in studies comparing dynamic stabilization devices with fusion. -The risk of ASD in fusion groups ranged from 0%-9% at follow-up times from 1-3 years with none reported in the dynamic groups in three studies. -Small-sample sizes and lack of long-term follow-up make definitive conclusions regarding the effectiveness of dynamic devices compared with fusion difficult.
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Reoperation
Very low Low Moderate High -The overall risk of reoperation appeared to be similar between treatment groups (0%-9%); indications varied across studies.
Other complications
Very low Low Moderate High -Overall, rates of complications other than ASD and reoperation appeared to be somewhat higher in those who had fusion. Variability in reporting of complications makes comparisons across studies difficult.
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DISCUSSION
Conclusions from this review are limited by the following:
• There is heterogeneity with respect to dynamic stabilization devices used across studies. The mechanism by which these devices work and their designs vary significantly. Each device has a dynamic and a fixed component, and these are not the same in each device. For instance, one type of dynamic stabilization involves rigid rods, yet screws which flex and extend with reference to the tulip head. Another type is a posterior band which wraps around the spinous processes. Others involve normal pedicle screws with a non-rigid rod. This tremendous variation in types of dynamic stabilization makes it even more difficult for a direct comparison between dynamic stabilization and fusion. Thus, when interpreting the findings of this systematic review, such heterogeneity must be considered.
• Although from these findings it appears that there is no ASD in the dynamic stabilization group, the followup was simply not long enough. The longest follow-up study was 3 years, and given the small numbers there is simply not enough power to identify ASD in such a short follow-up. Thus, these factors should be carefully considered when interpreting the lower rate of ASD in the dynamic stabilization group.
• Inadequate description of numbers of eligible patients screened and loss to follow-up raise the possibility of significant selection bias in three of these studies, calling their validity into question. All studies were CoE III.
• No definition of clinically meaningful improvement in VAS or ODI was provided and the proportion of patients with such improvement not reported.
• Evidence on the influence of dynamic systems on rates of ASD is limited. Criteria for determining ASD were not well described in studies, length of follow-up in some studies may have been too short to detect ASD, and studies may have had insufficient power to detect differences between treatments on this outcome. The ASD status of those lost to follow-up is unknown.
• Surveillance for and definitions of complications varied across studies.
• The longest follow-up was a mean of 3 years; thus, evidence-based conclusions regarding the long-term effectiveness and safety are not possible.
• In November 2009, the US Food and Drug Administration (FDA) reviewed clinical data comparing the Dynesys dynamic stabilization device and fusion for degenerative lumbar conditions. Based on these data, the FDA rejected the widespread use of Dynesys [7] . The FDA has also ordered post-market surveillance for class II dynamic stabilization systems and components which are intended for bone fusion [8] . Given the data currently published and the executive decision by the FDA, it remains unclear as to whether dynamic stabilization improves outcome or decreases ASD.
• Although dynamic stabilization would seem to decrease the rate of ASD, there simply is not enough long-term data to support that this is in fact happening.
• There are no data from comparative studies to support the use of dynamic stabilization devices over standard fusion techniques. 
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